Goldman Sachs’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
730,718
+414,488
| +131% | +$129K | ﹤0.01% | 4667 |
|
|
2025
Q1 | $155K | Sell |
316,230
-705,377
| -69% | -$345K | ﹤0.01% | 4730 |
|
|
2024
Q4 | $875K | Buy |
1,021,607
+203,841
| +25% | +$175K | ﹤0.01% | 3992 |
|
|
2024
Q3 | $6.95M | Buy |
817,766
+665,317
| +436% | +$5.66M | ﹤0.01% | 2528 |
|
|
2024
Q2 | $712K | Sell |
152,449
-562,759
| -79% | -$2.63M | ﹤0.01% | 3768 |
|
|
2024
Q1 | $4.86M | Buy |
715,208
+698,456
| +4,169% | +$4.75M | ﹤0.01% | 2588 |
|
|
2023
Q4 | $56.1K | Buy |
+16,752
| New | +$56.1K | ﹤0.01% | 4527 |
|
|
2022
Q4 | – | Sell |
-28,321
| Closed | -$26K | – | 5147 |
|
|
2022
Q3 | $26K | Buy |
28,321
+12,187
| +76% | +$11.2K | ﹤0.01% | 5119 |
|
|
2022
Q2 | $15K | Sell |
16,134
-78,530
| -83% | -$73K | ﹤0.01% | 5465 |
|
|
2022
Q1 | $200K | Buy |
94,664
+19,159
| +25% | +$40.5K | ﹤0.01% | 5095 |
|
|
2021
Q4 | $676K | Buy |
75,505
+13,415
| +22% | +$120K | ﹤0.01% | 4309 |
|
|
2021
Q3 | $1.03M | Buy |
62,090
+2,545
| +4% | +$42.3K | ﹤0.01% | 3945 |
|
|
2021
Q2 | $1.24M | Sell |
59,545
-11,113
| -16% | -$231K | ﹤0.01% | 3875 |
|
|
2021
Q1 | $1.33M | Buy |
70,658
+12,499
| +21% | +$234K | ﹤0.01% | 3717 |
|
|
2020
Q4 | $1.28M | Buy |
58,159
+45,711
| +367% | +$1.01M | ﹤0.01% | 3322 |
|
|
2020
Q3 | $258K | Buy |
12,448
+252
| +2% | +$5.22K | ﹤0.01% | 3966 |
|
|
2020
Q2 | $441K | Buy |
12,196
+1,441
| +13% | +$52.1K | ﹤0.01% | 3658 |
|
|
2020
Q1 | $352K | Buy |
+10,755
| New | +$352K | ﹤0.01% | 3665 |
|
|
2019
Q3 | – | Sell |
-24,654
| Closed | -$203K | – | 4223 |
|
|
2019
Q2 | $203K | Buy |
+24,654
| New | +$203K | ﹤0.01% | 3867 |
|